| Drug Name | zoptarelin doxorubicin |
|---|---|
| Other Drug Names | AEZS-108; |
| Chemical Name |
[6-D-lysine]human gonadoliberin-1 (LHRH) and doxorubicin
covalently linked together with glutaric acid: 5-oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-N6-[5-(2- {(2S,4S)-4-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]- 2,5,12-trihydroxy-7-methoxy-6,11-dioxo-1,2,3,4,6,11- hexahydrotetracen-2-yl}-2-oxoethoxy)-5-oxopentanoyl]-D-lysine- L-leucyl-L-arginyl-L-prolylglycinamide |
| Formula | C91H117N19O26 |
| Mol. Wt. | 1893.01438 |
| CAS No. | 139570-93-7 |
| UNII | 27844X2J29 |
| Target-based Actions | GNRH receptor modulator |
| ATC Codes | L02A |
| Originator Company | Aeterna Zentaris GmbH |
| Structure |
 |
Extended Information